These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 4892433)
1. Chemotherapy of leprosy. Shepard CC Annu Rev Pharmacol; 1969; 9():37-50. PubMed ID: 4892433 [No Abstract] [Full Text] [Related]
2. Drug resistance of Mycobacterium leprae, particularly to DDS. Rees RJ Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566 [No Abstract] [Full Text] [Related]
3. Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance. Pearson JM; Pettit JH; Rees RJ Int J Lepr Other Mycobact Dis; 1968; 36(2):171-8. PubMed ID: 4877115 [No Abstract] [Full Text] [Related]
4. Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae. Pattyn SR Lepr Rev; 1973 Sep; 43(3):126-36. PubMed ID: 4120832 [No Abstract] [Full Text] [Related]
7. The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action. Holmes IB; Hilson GR J Med Microbiol; 1972 May; 5(2):251-61. PubMed ID: 4555734 [No Abstract] [Full Text] [Related]
8. Chemotherapy in Leprosy. Leiker DL Int J Dermatol; 1975 May; 14(4):254-62. PubMed ID: 1093982 [No Abstract] [Full Text] [Related]
9. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment. Shepard CC; Levy L; Fasal P Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029 [No Abstract] [Full Text] [Related]
10. [On the chemoresistance of the Hansen bacillus and the treatment of leprosy with drug associations]. Floch HA Bull Soc Pathol Exot Filiales; 1966; 59(2):188-92. PubMed ID: 6012833 [No Abstract] [Full Text] [Related]
11. Drug resistance in leprosy. Browne SG Lepr Rev; 1974 Sep; 45(3):276-8. PubMed ID: 4612275 [No Abstract] [Full Text] [Related]
12. Experimental chemotherapy in leprosy, then and now. Shepard CC Int J Lepr Other Mycobact Dis; 1973; 41(3):307-19. PubMed ID: 4136732 [No Abstract] [Full Text] [Related]
13. Correlation of laboratory and clinical data during treatment of leprosy. Pattyn SR; Rollier R; Rollier MR; De Muynck A; Janssens PG; Verdoolaeghe-Van Loo G Ann Soc Belg Med Trop; 1972; 52(6):537-48. PubMed ID: 4574223 [No Abstract] [Full Text] [Related]
14. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses. Browne SG Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048 [No Abstract] [Full Text] [Related]
15. The incidence of DDS resistance in lepromatous patients in Costa Rica: their metabolic disposition of DDS. Peters JH; Shepard CC; Gordon GR; Rojas AV; Elizondo DS Int J Lepr Other Mycobact Dis; 1976; 44(1-2):143-51. PubMed ID: 776849 [No Abstract] [Full Text] [Related]
16. [Dynamics of establishing resistance of M. leprae to dapsone and rifampicin in Martinique]. Constant-Desportes-Relouzat M; Grosset J; Guelpalauras CC; Salvini B; Cales-Quist D Acta Leprol; 1986; 4(3):293-300. PubMed ID: 3551468 [No Abstract] [Full Text] [Related]
17. Dapsone drug resistance in the MDT era. Roche PW; Neupane KD; Failbus SS; Butlin CR Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097 [No Abstract] [Full Text] [Related]
18. Activity of repository sulfones against Mycobacterium leprae in mice. Shepard CC Proc Soc Exp Biol Med; 1967 Feb; 124(2):430-3. PubMed ID: 5335647 [No Abstract] [Full Text] [Related]
19. Combined clofazimine- and dapsone-resistant leprosy. A case report. Kar HK; Bhatia VN; Harikrishnan S Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of drug resistance in Dharmapuri and A. Pallipatti areas of Tamil Nadu. Sreevatsa ; Ramu G; Desikan KV Indian J Lepr; 1985; 57(2):376-82. PubMed ID: 3908580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]